According to its important role in promoting autophagy and lysosome, TFEB has become an important therapeutic target for diseases involving excess ROS and autophagy dysfunction, such as AD, PD, and atherosclerosis (see Figure 2 for details about TFEB and autophagy). This evidence concerns the gene TFEB and atherosclerosis.